Moreover, depletion of peritoneal TAMs in a syngeneic ovarian cancer mouse model was found to reduce ascites formation and peritoneal metastasis, concurrent with a reduction of ascitic VEGF-A [86]. This evidence concerns the gene VEGFA and ovarian cancer.